Table 4.
Description | Protein ID | Ref# | F-LCR | M-LCR | F-HCR | M-HCR | fold diff. |
---|---|---|---|---|---|---|---|
Respiratory chain | |||||||
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 10, mitochondrial |
NDUAA | 535 | 0.643 ± 0.292 | 0.721 ± 0.229 | 1.204 ± 0.302 | 1.182 ± 0.045 | −2.06 |
ATP synthase subunit alpha | ATPA | 338 | 0.956 ± 0.044 | 1.007 ± 0.098 | 1.100 ± 0.062 | 1.132 ± 0.100 | −1.08 |
ATP synthase subunit alpha | ATPA | 314 | 0.936 ± 0.048 | 0.967 ± 0.080 | 1.154 ± 0.094 | 1.180 ± 0.085 | −1.18 |
aATP synthase subunit beta | ATPB | 345 | 0.861 ± 0.028 | 0.929 ± 0.059 | 1.043 ± 0.059 | 1.012 ± 0.113 | −1.10 |
ATP synthase subunit d | ATP5H | 861 | 1.054 ± 0.052 | 1.134 ± 0.122 | 1.191 ± 0.080 | 1.289 ± 0.107 | −1.04 |
Mitochondrial protein import | |||||||
a60 kDa heat shock protein, mitochondrial | CH60 | 238 | 1.109 ± 0.112 | 1.047 ± 0.071 | 1.258 ± 0.117 | 1.170 ± 0.044 | −1.10 |
aStress-70 protein, mitochondrial | GRP75 | 107 | 1.160 ± 0.078 | 1.061 ± 0.027 | 1.237 ± 0.070 | 1.190 ± 0.077 | −1.08 |
aHeat shock cognate 71 kDa protein | HSP7C | 53 | 0.932 ± 0.105 | 1.167 ± 0.160 | 1.155 ± 0.096 | 1.329 ± 0.143 | −1.11 |
Pyruvate dehydrogenase complex | |||||||
Pyruvate dehydrogenase E1 component subunit beta | ODPB | 635 | 0.991 ± 0.043 | 1.018 ± 0.055 | 1.132 ± 0.026 | 1.181 ± 0.099 | −1.10 |
Dihydrolipoyllysine-residue acetyltransferase E2 component of pyruvate dehydrogenase complex |
ODP2 | 165 | 0.970 ± 0.043 | 1.138 ± 0.090 | 1.113 ± 0.034 | 1.222 ± 0.065 | −1.08 |
Tricarboxylic acid cycle | |||||||
Fumarate hydratase | FUMH | 423 | 0.599 ± 0.304 | 0.508 ± 0.198 | 1.458 ± 0.254 | 1.622 ± 0.335 | −3.12 |
Fumarate hydratase | FUMH | 425 | 0.768 ± 0.121 | 0.822 ± 0.120 | 1.325 ± 0.177 | 1.374 ± 0.0115 | −1.54 |
Fumarate hydratase | FUMH | 426 | 0.717 ± 0.269 | 0.599 ± 0.163 | 1.471 ± 0.282 | 1.595 ± 0.222 | −2.35 |
Fatty acid metabolism | |||||||
Very long-chain specific acyl-CoA dehydrogenase | ACADV | 65 | 0.878 ± 0.173 | 0.866 ± 0.121 | 1.074 ± 0.049 | 1.074 ± 0.071 | −1.32 |
Enoyl-CoA hydratase | ECHM | 762 | 0.890 ± 0.064 | 0.885 ± 0.078 | 1.158 ± 0.100 | 1.026 ± 0.074 | −1.20 |
Amino acid metabolism | |||||||
3-mercaptopyruvate sulfurtransferase | THTM | 670 | 0.899 ± 0.040 | 0.883 ± 0.047 | 1.1074 ± 0.079 | 0.969 ± 0.043 | −1.18 |
b3-hydroxyisobutyrate dehydrogenase | 3HIDH | 677 | 1.031 ± 0.065 | 1.025 ± 0.044 | 1.185 ± 0.030 | 1.154 ± 0.134 | −1.13 |
abAspartate aminotransferase, mitochondrial | AATM | 523 | 0.809 ± 0.061 | 0.848 ± 0.072 | 1.039 ± 0.170 | 0.922 ± 0.053 | −1.16 |
Ketone body metabolism | |||||||
Succinyl-CoA:3-ketoacid-coenzyme A transferase 1 | SCOT1 | 164 | 0.930 ± 0.104 | 0.947 ± 0.093 | 1.093 ± 0.051 | 1.082 ± 0.084 | −1.17 |
Glycolysis | |||||||
Beta-enolase | ENOB | 341 | 1.104 ± 0.033 | 0.996 ± 0.053 | 1.146 ± 0.077 | 1.134 ± 0.099 | −1.07 |
Beta-enolase | ENOB | 410 | 2.121 ± 1.562 | 1.569 ± 0.435 | 1.017 ± 0.246 | 0.530 ± 0.247 | +2.57 |
Beta-enolase | ENOB | 379 | 0.879 ± 0.063 | 1.084 ± 0.104 | 0.870 ± 0.020 | 0.858 ± 0.018 | +1.06 |
Glyceraldehyde-3-phosphate dehydrogenase | G3P | 413 | 1.553 ± 0.374 | 1.538 ± 0.409 | 0.679 ± 0.457 | 0.426 ± 0.082 | +2.76 |
Cytoskeletal | |||||||
Tripartite motif-containing protein 72 | TRI72 | 261 | 1.272 ± 0.112 | 1.143 ± 0.116 | 0.851 ± 0.229 | 0.869 ± 0.127 | +1.28 |
Tripartite motif-containing protein 72 | TRI72 | 269 | 0.655 ± 0.065 | 0.689 ± 0.091 | 1.306 ± 0.700 | 1.2302 ± 0.338 | −1.93 |
Lamin-A | LMNA | 329 | 0.979 ± 0.033 | 1.015 ± 0.061 | 1.115 ± 0.064 | 1.139 ± 0.117 | −1.07 |
Miscellaneous | |||||||
Protein disulphide-isomerase A3 | PDIA3 | 206 | 1.808 ± 0.506 | 1.765 ± 1.051 | 0.424 ± 0.106 | 0.448 ± 0.070 | +2.83 |
Protein disulphide-isomerase A3 | PDIA3 | 220 | 1.727 ± 0.426 | 1.464 ± 0.635 | 1.084 ± 0.146 | 0.722 ± 0.125 | +1.57 |
bProtein disulphide-isomerase A3 | PDIA3 | 210 | 0.774 ± 0.399 | 0.669 ± 0.265 | 1.139 ± 0.150 | 1.146 ± 0.118 | −1.75 |
abProtein NDRG2 | NDRG2 | 433 | 0.872 ± 0.191 | 0.985 ± 0.072 | 1.189 ± 0.186 | 1.222 ± 0.152 | −1.28 |
abProtein NDRG2 | NDRG2 | 431 | 0.890 ± 0.197 | 0.920 ± 0.102 | 1.165 ± 0.092 | 1.098 ± 0.127 | −1.37 |
Serine protease inhibitor A3K | SPA3K | 123 | 1.159 ± 0.316 | 1.435 ± 0.261 | 0.777 ± 0.130 | 1.008 ± 0.246 | +1.53 |
Serine protease inhibitor A3K | SPA3K | 139 | 1.098 ± 0.278 | 1.351 ± 0.141 | 0.735 ± 0.057 | 1.031 ± 0.112 | +1.43 |
Voltage-dependent anion-selective channel protein 1 | VDAC1 | 385 | 1.317 ± 0.320 | 1.245 ± 0.249 | 0.944 ± 0.128 | 0.830 ± 0.191 | +1.33 |
Voltage-dependent anion-selective channel protein 1 | VDAC1 | 650 | 0.945 ± 0.086 | 0.973 ± 0.090 | 1.102 ± 0.119 | 1.166 ± 0.035 | −1.16 |
Aspartyl-tRNA synthetase, cytoplasmic | SYDC | 156 | 0.831 ± 0.103 | 0.928 ± 0.079 | 1.022 ± 0.059 | 1.084 ± 0.111 | −1.19 |
Aldehyde dehydrogenase, mitochondrial | ALDH2 | 337 | 1.058 ± 0.079 | 1.013 ± 0.102 | 1.176 ± 0.100 | 1.253 ± 0.063 | −1.16 |
Creatine kinase M-type | KCRM | 541 | 0.738 ± 0.242 | 0.853 ± 0.238 | 1.275 ± 0.227 | 1.303 ± 0.279 | −1.79 |
Hypoxanthine-guanine phosphoribosyltransferase | HPRT | 757 | 0.768 ± 0.138 | 0.822 ± 0.052 | 1.060 ± 0.082 | 0.874 ± 0.114 | −1.31 |
Serine protease inhibitor A3L | SPA3L | 539 | 1.557 ± 0.248 | 1.688 ± 0.395 | 0.762 ± 0.657 | 0.311 ± 0.055 | +3.18 |
Protein description and protein ID relate to the Swiss-Prot database entry identified from Mascot searches of CID and ETD MS/MS spectra. Ref# is the gel spot number created during image analysis and is consistent with Fig. 1 and the World-2DPAGE online graphical interface, available at http://world-2dpage.expasy.org/repository/0069/. Relative spot volumes (mean ± SD) are reported for each independent group, i.e. male high-capacity runner (M-HCR), female low-capacity runner (F-LCR) etc. Fold difference values are reported for spots exhibiting significant differences in expression at P < 0.05 at a false discovery rate of <10%.
Present in Table S3 from {Bell 2009} containing genes from the longevity interactome (core or primary interactors) that are differentially expressed in young versus old human muscle.
Contains evidence of post-translational modification: acetylation or phosphorylation (Supplementary Table S1).